Epinephrine is associated with both erectile dysfunction and lower urinary tract symptoms

Fertility and Sterility

Volumn 93, Issue 3, 2010, Pages 837-842

  Trussell, J C ^a   Kunselman, Allen R ^a   Legro, Richard S ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

epinephrine; Erectile dysfunction; insulin resistance; lower urinary tract symptoms; metabolic syndrome

Indexed keywords

ADRENALIN;

ADRENALIN BLOOD LEVEL; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ERECTILE DYSFUNCTION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INSULIN RESISTANCE; LABORATORY TEST; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; QUESTIONNAIRE; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; EPINEPHRINE; ERECTILE DYSFUNCTION; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; URINATION DISORDERS; YOUNG ADULT;

EID: 75749137797     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.10.034     Document Type: Article

References (48)

1. Sun P., Cameron A., Seftel A., Shabsigh R., Niederberger C., and Guay A. Erectile dysfunction-an observable marker of diabetes mellitus? A large national epidemiological study. J Urol 176 (2006) 1081-1085
2. Schiel R., and Muller U.A. Prevalence of sexual disorders in a selection-free diabetic population (JEVIN). Diab Res Clin Pract 44 (1999) 115-121
3. Kashiwagi A., Shinozaki K., Nishio Y., Okamura T., Toda N., and Kikkawa R. Free radical production in endothelial cells as a pathological factor for vascular dysfunction in the insulin resistant state. Diabetes Res Clin Pract 45 (1999) 199-203
4. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 187 (2002) 356-359
5. Wheatcroft S.B., Williams I.L., Shah A.M., and Kearney M.T. Pathophysiological implications of insulin. Diabetes 20 (2003) 255-268
6. Rosen R.C., Cappelleri J.C., Smith M.D., Lipsky J., and Pena B.M. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic too for erectile dysfunction. Int J Impot Res 11 (1999) 319-326
7. Barry M.J., Fowler F.J., O'Leary M.P., Bruskewitz R.C., Holtgrewe H.L., Mebust W.K., et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148 (1992) 1549-1557
8. Khan M.H., Sinoway L.I., and Maclean D.A. Effects of graded LBNP on MSNA and interstitial norepinephrine. Am J Physiol Heart Circ Physiol 283 (2002) H2038-H2044
9. Baily RG, Leuenberger U, Leaman G, Silber D, Sinoway LI. Norepinephrine kinetics and cardiac output during non-hypotensive lower body negative pressure. Am J Physiol 991;260:1708-12.
10. Li J., King N.C., and Sinoway L.I. Interstitial ATP and norepinephrine concentrations in active muscle. Circulation 111 (2005) 2748-2751
11. Legro R.S., Gnatuk C.L., Kunselman A.R., and Dunaif A. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 90 (2005) 3236-3242
12. Legro R.S., Finegood D., and Dunaif A. A fasting glucose to insulin ration is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83 (1998) 2694-2698
13. Legro R.S., Bentley-Lewis R., Driscoll D., Wang S.C., and Dunaif A. Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. J Clin Endocrinol Metab 87 (2002) 2128-2133
14. Matsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999) 1462-1470
15. Cook S., and Scherrer U. Insulin resistance, a new target for nitric oxide-delivery drugs. Fundam Clin Pharmacol 16 (2002) 441-453
16. Bansal T.C., Guay A.T., Jacobson J., Woods B.O., and Nesto R.W. Incidence of metabolic syndrome and insulin resistance in a population with organic erectile dysfunction. J Sex Med 2 (2005) 96-103
17. Esposito K., Giugliano F., DiPalo C., Giugliano G., Marfella R., D'Andrea F., et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291 (2004) 2978-2984
18. Esposito K., and Giugliano D. Obesity, the metabolic syndrome, and sexual dysfunction. Int J Impot 17 (2005) 391-398
19. Sun P., and Swindle R. Are men with erectile dysfunction more likely to have hypertension than men without erectile dysfunction. A naturalistic national cohort study. J Urol 174 (2005) 244-248
20. Vlachopoulos C., Rokkas K., Ioakeimidis N., and Stefanadis C. Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links. Eur Urol 52 (2007) 1590-1600
21. Bal K., Oder M., Sahin A.S., Karatas C.T., Demir O., Can E., et al. Prevalence of metabolic syndrome and its association with erectile dysfunction among urologic patients: metabolic backgrounds of erectile dysfunction. Urology 69 (2007) 356-360
22. Ahmed M.H. Metabolic syndrome and endothelial dysfunction and associated high proportions of erectile dysfunction in men: innocent bystanders or accessories to the crime?. Diabetes Res Clin Pract 75 (2007) 370-371
23. Muller A., and Mulhall J.P. Cardiovascular disease, metabolic syndrome and erectile dysfunction. Curr Opin Urol 16 (2006) 435-443
24. Demir T., Demir O., Kefi A., Comlekci A., Yesil S., and Esen A. Prevalence of erectile dysfunction in patients with metabolic syndrome. Int J Urol 13 (2006) 385-388
25. Burnett A.L. Metabolic syndrome, endothelial dysfunction, and erectile dysfunction: association and management. Curr Urol Rep 6 (2005) 470-475
26. Seftel A.D. Erectile dysfunction a decade later: another paradigm shift. J Urol 176 (2006) 10-11
27. Kupelian V., Shabsigh R., Araujo A.B., O'Donnell A.B., and McKinlay J.B. Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study. J Urol 176 (2006) 222-226
28. Cheng J.Y., and Ng E.M. Body mass index, physical activity and erectile dysfunction: an U-shaped relationship from population-based study. Int J Obes (Lond) 31 (2007) 1571-1578
29. Kratzik C.W., Schatzl G., Lunglmayr G., Rucklinger E., and Huber J. The impact of age, body mass index and testosterone on erectile dysfunction. J Urol 174 (2005) 240-243
30. Lukacs B., Leplege A., Thibault P., and Jardin A. Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results. Urology 48 (1996) 731-740
31. Macfarlane G.J., Botto H., Sagnier P.P., Teillac P., Richard F., and Boyle P. The relationship between sexual life and urinary condition in the French community. J Clin Epidemiol 49 (1996) 1171-1176
32. Frankel S.J., Donovan J.L., Peters T.I., Abrams P., Dabhoiwala N.F., Osawa D., et al. Sexual function in men with lower urinary tract symptoms. J Clin Epidemiol 51 (1998) 677-685
33. Martin-Morales A., Sanchez-Cruz J.J., Saenz de Tejada I., Rodriguez-Vela L., Jiménez-Cruz J.F., and Burgos-Rodriguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol 166 (2001) 569-575
34. Braun M.H., Sommer F., Haupt G., Mathers M.J., Reifenrath B., and Engelmann U.H. Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical aging male symptoms? Results of the Cologne Male Survey. Eur Urol 44 (2003) 588-594
35. Boyle P., Robertson C., Mazzetta C., Keech M., Hobbs R., Fourcade R., et al. The association between lower urinary tract symptoms and erectile dysfunction in four centers: the UrEpik study. BJU Int 92 (2003) 719-725
36. Rosen R., Altwein J., Boyle P., Kirby R.S., Lukacs B., Meuleman E., et al. Lower urinary tract symptoms and male sexual dysfunction: the Multinational Survey of the Aging Male (MSAM-7). Eur Urol 44 (2003) 637-649
37. Vallancien G., Emberton M., Harving N., and van Moorselaar R.J. Alf-One Study Group. Sexual dysfunction in 1274 European men suffering from lower urinary tract symptoms. J Urol 169 (2003) 2257-2261
38. Li M.K., Garcia L.A., and Rosen R. Lower urinary tract symptoms and male sexual dysfunction in Asia: a survey of aging men from five Asian countries. BJU Int 96 (2005) 1339-1354
39. McVary K.T., Foley J., and Bautista O. The association of lower urinary tract symptoms (LUTS) with sexual function in men participating in a clinical trial of medical therapy for benign prostatic hyperplasia. [abstract]. J Urol 169 (2003) A1252
40. McVary K. Lower urinary tract symptoms and sexual function: epidemiology and pathophysiology. BJU Int 97 (2006) 23-28
41. Owlya R., Vollenweider L., Trueb L., Sartori C., Lepori M., Nicaod P., et al. Cardiovascular and sympathetic effects of nitric oxide inhibition at rest and during static exercise in humans. Circulation 96 (1997) 3897-3903
42. Jordan J., Tank J., Stoffels M., Franke G., Christensen N.J., Luft F.C., et al. Interaction between beta-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism. J Clin Endocrinol Metab 86 (2001) 2803-2810
43. Sigola L.B., and Zinyama R.B. Adrenaline inhibits macrophage nitric oxide production thought beta1 and beta2 adrenergic receptors. Immunology 100 (2000) 359-363
44. Zinyama R.B., Bancroft G.J., and Sigola L.B. Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumour necrosis factor-alpha and interleukin-10. Immunology 104 (2001) 439-446
45. Collins J.L., Vodovotz Y., Yoneyama T., Hatakeyama K., Green A.M., and Billiar T.R. Catecholamines decrease nitric oxide production by cytokine-stimulated hepatocytes. Surgery 130 (2001) 256-264
46. Adding L.C., Agvald P., Artlich A., and Gustafsson L.E. Activation of sympathoadrenomedullary system increases pulmonary nitric oxide production in the rabbit. Eur J Pharmcol 411 (2001) 311-318
47. Golomb E., Rosenzweig N., Eilam R., and Abramovici A. Spontaneous hyperplasia of the ventral lobe of the prostate in aging genetically hypertensive rates. J Androl 21 (2000) 58-64
48. McVary K.T., Monnig W., Camps J.L., Young J.M., Tseng L., and van den Ende G. Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double blind trial. J Urol 177 (2007) 1071-1077